Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Certus Sting Relief Prep Pad

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Benzocaine 0.06 mL/1 mL
Other brand names
Dosage form
Swab
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2011
Label revision date
April 8, 2011
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Benzocaine 0.06 mL/1 mL
Other brand names
Dosage form
Swab
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2011
Label revision date
April 8, 2011
Manufacturer
Certus Medical, Inc.
Registration number
part348
NDC root
75990-7008
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Certus Sting Relief Prep Pad is designed to provide temporary relief from pain and itching caused by minor burns, scrapes, and insect bites. This product can help soothe discomfort and promote a sense of comfort when dealing with these common skin irritations.

If you experience minor skin injuries or insect bites, using Certus Sting Relief Prep Pad may help alleviate your symptoms and make you feel more at ease.

Uses

You can use this medication for temporary relief of pain and itching caused by minor burns, scrapes, and insect bites. It helps soothe discomfort and allows you to feel more comfortable while your skin heals.

Rest assured, there are no known teratogenic effects (which means it doesn't cause birth defects) associated with this medication, making it a safer option for use.

Dosage and Administration

You can apply this medication to the affected area up to 3 to 4 times a day if you are an adult or a child who is 2 years old or older. Make sure to follow this guideline to ensure the best results.

If your child is under 2 years old, it’s important to consult a physician (doctor) before using this medication. They can provide the best advice tailored to your child's needs.

What to Avoid

It's important to use this medication safely. You should never apply it to your eyes, as this can cause irritation or damage. If the medication accidentally comes into contact with your eyes, make sure to flush them with water immediately to prevent any adverse effects.

Currently, there are no specific contraindications, controlled substance classifications, or concerns regarding abuse, misuse, or dependence associated with this medication. Always follow the instructions provided to ensure your safety and well-being.

Side Effects

It's important to note that this product is for external use only and should be kept away from fire or flames, as it is flammable. To ensure its effectiveness, store it at room temperature, ideally between 15°C and 30°C (59°F and 86°F).

Please be aware of these precautions to use the product safely and effectively.

Warnings and Precautions

This product is for external use only, so please avoid using it on your internal body parts. It is also flammable, so keep it away from fire or flames to prevent any accidents. Make sure to store it at room temperature, ideally between 15°C and 30°C (59°F and 86°F), to maintain its effectiveness.

If you accidentally swallow this product, seek emergency medical help immediately or contact a Poison Control Center. It's important to act quickly in such situations to ensure your safety.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While the specific signs of an overdose are not detailed, common symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's crucial to provide them with as much information as possible about the substance taken and the amount, if known. Remember, acting quickly can make a significant difference in your health and safety.

Pregnancy Use

There is currently no specific information available regarding the use of Certus Sting Relief Prep Pad (benzocaine swab) during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions for pregnant individuals have not been addressed in the drug insert.

If you are pregnant or planning to become pregnant, it is always best to consult with your healthcare provider before using any medication, including over-the-counter products like this one. They can provide personalized advice based on your health and circumstances.

Lactation Use

If you are breastfeeding, you can use Certus Sting Relief Prep Pad without specific warnings or recommendations against it. Currently, there are no known concerns about this product being passed into breast milk or any risks to your nursing infant. This means you can feel confident using it while continuing to breastfeed.

Pediatric Use

You can use this medication on your child's affected area up to 3 to 4 times a day if they are 2 years old or older. However, if your child is under 2 years of age, it's important to consult with a physician (doctor) before using it. Always follow these guidelines to ensure your child's safety and well-being.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations for the medication do not include special monitoring or safety considerations tailored for patients with renal impairment (kidney issues).

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your kidney health. They can provide guidance based on your individual situation.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations for the medication do not change based on liver impairment. However, it’s always a good idea to discuss your liver health with your healthcare provider before starting any new medication. They can help ensure that your treatment is safe and effective for you.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking. In this case, there are no specific drug interactions or laboratory test interactions noted, which means that this medication is generally considered safe to use alongside other treatments and tests. However, every individual is different, and your healthcare provider can help ensure that your overall treatment plan is safe and effective for you.

Always remember that discussing your full list of medications and any lab tests with your healthcare provider is crucial. This way, you can avoid any potential issues and receive the best care tailored to your needs.

Storage and Handling

To ensure the best performance of your product, store it at room temperature, ideally between 15 to 30 °C (59 to 86 °F). This temperature range helps maintain the product's effectiveness and safety.

When handling the product, make sure to do so with clean hands and in a clean environment to avoid contamination. Always follow any specific instructions provided with the product for safe use and disposal.

Additional Information

You should apply the medication to the affected area no more than 3 to 4 times a day if you are an adult or a child aged 2 years or older. If the patient is under 2 years old, it's important to consult a physician before use. There are no additional details available regarding laboratory tests, abuse potential, or patient counseling.

FAQ

What is Certus Sting Relief Prep Pad used for?

Certus Sting Relief Prep Pad is used for temporary relief of pain and itching associated with minor burns, scrapes, and insect bites.

How often can I apply Certus Sting Relief Prep Pad?

You can apply it to the affected area not more than 3 to 4 times daily for adults and children 2 years of age or older. For children under 2 years, consult a physician.

Are there any contraindications for using Certus Sting Relief Prep Pad?

No specific contraindications are mentioned for Certus Sting Relief Prep Pad.

What precautions should I take when using this product?

This product is for external use only and is flammable, so keep it away from fire or flame. Store it at room temperature between 15°C - 30°C (59°F - 86°F).

What should I do if I accidentally get Certus Sting Relief Prep Pad in my eyes?

If contact occurs, flush your eyes with water immediately.

Is Certus Sting Relief Prep Pad safe to use during pregnancy or while nursing?

There is no specific information regarding the use of Certus Sting Relief Prep Pad during pregnancy or nursing, so consult your physician for advice.

What should I do if I swallow Certus Sting Relief Prep Pad?

If swallowed, get medical help or contact a Poison Control Center right away.

Packaging Info

Below are the non-prescription pack sizes of Certus Sting Relief Prep Pad (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Certus Sting Relief Prep Pad.
Details

Drug Information (PDF)

This file contains official product information for Certus Sting Relief Prep Pad, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

Certus Sting Relief Prep Pad is provided in a pouch labeled 210004. The product is designed for topical application to relieve discomfort associated with insect stings. The prep pad is formulated to deliver effective relief through its active ingredients, which are not specified in the provided data. The pouch ensures the sterility and integrity of the prep pad until use.

Uses and Indications

This drug is indicated for the temporary relief of pain and itching associated with minor burns, scrapes, and insect bites.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be applied to the affected area no more than 3 to 4 times daily for adults and children aged 2 years and older. For children under 2 years of age, it is recommended to consult a physician prior to use.

Contraindications

Use of this product is contraindicated in the eyes. In the event of contact with the eyes, it is essential to flush the eyes with water immediately. No other contraindications have been specified.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame to prevent any risk of ignition.

It is essential to store the product at room temperature, specifically between 15°C and 30°C (59°F and 86°F), to maintain its efficacy and safety.

In the event of accidental ingestion, immediate medical assistance should be sought. Healthcare professionals are advised to contact a Poison Control Center without delay to ensure appropriate management of the situation.

Side Effects

Patients should be aware that the product is for external use only and is flammable; it should be kept away from fire or flame to prevent any potential hazards.

In clinical practice, it is important to store the product at room temperature, specifically between 15°C and 30°C (59°F and 86°F), to maintain its efficacy and safety.

No specific adverse reactions have been reported in clinical trials or postmarketing experiences beyond the outlined warnings and precautions.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Certus Sting Relief Prep Pad (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Certus Sting Relief Prep Pad.
Details

Pediatric Use

Pediatric patients aged 2 years and older may apply the medication to the affected area no more than 3 to 4 times daily. For children under 2 years of age, it is recommended to consult a physician prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population, given the lack of targeted data.

Pregnancy

There is no specific information regarding the use of Certus Sting Relief Prep Pad (benzocaine swab) during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when considering the use of this product in pregnant women, as the potential effects on fetal outcomes are not established. It is advisable to weigh the benefits against any unknown risks when recommending this product to women of childbearing potential.

Lactation

There are no specific warnings or recommendations regarding the use of Certus Sting Relief Prep Pad in lactating mothers. Additionally, there are no statements concerning the potential for excretion of the product in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no specific information regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, and respiratory distress.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Additionally, it is recommended to consult local poison control centers or toxicology experts for guidance on specific management strategies tailored to the substance involved in the overdose. Continuous assessment and supportive measures are critical in ensuring patient safety and optimizing outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that in the event of accidental ingestion, it is crucial to seek medical assistance immediately or contact a Poison Control Center. This prompt action is essential to ensure the safety and well-being of the patient.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature, maintaining a range of 15 to 30 °C (59 to 86 °F). Proper storage conditions are crucial to ensure the integrity and efficacy of the product.

Additional Clinical Information

Patients should apply the medication to the affected area no more than 3 to 4 times daily. This dosage is applicable for adults and children aged 2 years and older. For children under 2 years of age, it is advised to consult a physician prior to use. No further information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Certus Sting Relief Prep Pad, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Certus Sting Relief Prep Pad, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.